Latest News in the pharma Industry

Top Stories

EU Approves Teva & Cephalon Acquisition

EU Approves Teva & Cephalon Acquisition

14 Oct 2011

With this approval from the European Commission, the two companies have now obtained all regulatory approvals required to close the transaction.

Read more 
Pfizer & deCODE Ink Pact for Sequence Variants Discovery

Pfizer & deCODE Ink Pact for Sequence Variants Discovery

14 Oct 2011

The two companies will jointly analyze patient genomes to search for sequence variants that would be useful for understanding drug targets and discovering novel drug targets.

Read more 
Canada's Paladin Labs Acquires Labopharm

Canada's Paladin Labs Acquires Labopharm

13 Oct 2011

Canadian pharmaceutical firm Paladin Labs completes the acquisition of drug developer Labopharm. The acquisition will help them build upon their existing operational capabilities.

Read more 
GlycoMimetics & Pfizer Ink Licensing Deal

GlycoMimetics & Pfizer Ink Licensing Deal

12 Oct 2011

The potential value of the agreement for GlycoMimetics is approximately $340 million, including an upfront payment as well as development, regulatory and commercial milestones.

Read more 
BMS Foundation Collaborates with WHO Stop TB Department

BMS Foundation Collaborates with WHO Stop TB Department

12 Oct 2011

The collaboration is established for a two-year pilot initiative to strengthen community based prevention, care and control of tuberculosis including co-infection with HIV in five African countries.

Read more 
EMA Supports World Arthritis Day

EMA Supports World Arthritis Day

12 Oct 2011

World Arthritis Day is held each year on 12 October. To date, 18 medicines for patients with rheumatoid arthritis have been authorised on the recommendation of the Agency.

Read more 
US Signs MoU with Russia to Improve Medicine Quality

US Signs MoU with Russia to Improve Medicine Quality

12 Oct 2011

The two countries will cooperate in several fields to improve the quality of medicines in their respective countries.

Read more 
German Biotech Firm Apceth Extending Top Management

German Biotech Firm Apceth Extending Top Management

11 Oct 2011

German biotech company Apceth has extended its top management after Prof. Ralf Huss, previously Global Head of the Therapeutic Cell Initiative at Roche, joined the management board of apceth on October 1st.

Read more 
AstraZeneca Plans New $200M Manufacturing Facility in China

AstraZeneca Plans New $200M Manufacturing Facility in China

11 Oct 2011

The new site will produce both intravenous and oral solid medicines and will enable AstraZeneca to meet the growing demand for its products in the country.

Read more 
AstraZeneca to Cut 400 Jobs in the US

AstraZeneca to Cut 400 Jobs in the US

11 Oct 2011

The decision of the job cuts comes as AstraZeneca faces increasing pressure from generics as the company approaches a 2016 patent cliff.

Read more 
Exonhit Enters Into Research Agreement With Pfizer

Exonhit Enters Into Research Agreement With Pfizer

11 Oct 2011

French biotech company Exonhit will work with Pfizer for the identification of new Alzheimer's disease biomarkers.

Read more 
Sanofi & Genzyme Announce TEMSO Data

Sanofi & Genzyme Announce TEMSO Data

10 Oct 2011

Sanofi and its subsidiary Genzyme have announced the results of the pivotal Phase III TEMSO study with investigational once-daily oral medication teriflunomide.

Read more